Kyntra Bio (KYNB) Inventory (2018 - 2026)
Kyntra Bio (KYNB) posted Inventory of $3.4 million for Q1 2026, down 9.59% sequentially from $3.7 million in Q4 2025, and up 7.26% YoY from $3.2 million in Q1 2025.
Kyntra Bio (KYNB) Inventory (2018 - 2026) Analysis & Trends
Kyntra Bio has reported Inventory for 9 years, with the latest figure at $3.4 million in Q1 2026.
- Quarterly Inventory rose 7.26% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 7.26% YoY) and the FY2025 annual result came in at $3.7 million, up 18.64% from the prior year.
- Inventory eased to $3.4 million in Q1 2026 per KYNB's latest filing, from $3.7 million in the prior quarter.
- Over five years, Inventory peaked at $43.1 million in Q1 2022 and troughed at $3.2 million in Q4 2024.
- A 5-year average of $23.7 million and a median of $25.4 million in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2025: Inventory soared 107.41% in 2022, then slumped 88.46% in 2025.
- Over 5 years, Inventory stood at $40.4 million in 2022, then plunged by 57.53% to $17.2 million in 2023, then sank by 81.63% to $3.2 million in 2024, then increased by 18.64% to $3.7 million in 2025, then declined by 9.59% to $3.4 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $3.4 million, $3.7 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Kyntra Bio | 29.83 Mn | 29.83 Mn | 1.47 Mn | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.38 Mn |
| Dec 31, 2025 | 3.74 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.86 Mn |
| Mar 31, 2025 | 3.16 Mn |
| Dec 31, 2024 | 3.16 Mn |
| Sep 30, 2024 | 23.94 Mn |
| Jun 30, 2024 | 25.40 Mn |
| Mar 31, 2024 | 27.34 Mn |
| Dec 31, 2023 | 17.17 Mn |
| Sep 30, 2023 | 40.70 Mn |
| Jun 30, 2023 | 41.18 Mn |
| Mar 31, 2023 | 42.46 Mn |
| Dec 31, 2022 | 40.44 Mn |
| Sep 30, 2022 | 39.95 Mn |
| Jun 30, 2022 | 40.90 Mn |
| Mar 31, 2022 | 43.07 Mn |
| Dec 31, 2021 | 31.02 Mn |
| Sep 30, 2021 | 29.32 Mn |